Aurora Cannabis Inc. (a leading medical cannabis company from Canada) unveiled a new cannabis brand called Daily Special™ in Germany. The goal is to offer reliable, high-quality cannabis at an affordable price. This launch comes after the company’s great performance recently and adds to the growing medical cannabis market in Germany.
With this launch, Aurora is focusing on giving patients more options, making products more affordable, and ensuring high-quality, pharmaceutical-grade cannabis that follows strict global standards.
Starting December 19, 2025, Daily Special will be available at pharmacies and through telemedicine platforms in Germany. The first product is a sativa-dominant strain created from Gelonade × Biscotti, with 21-23% THC and less than 1% CBD. It has a strong aroma, including citrus, earthy sweetness, and diesel-like scents, making it stand out as a premium product.
Aurora, which has one of the largest cannabis genetic libraries and a wide range of high-quality products, is ready to help grow the medical cannabis market in Germany and continue expanding patient access as new opportunities come up.
According to Coherent Market Insights, the Medicinal Cannabis Market is expected to grow at a CAGR of 23.1% from 2025 to 2032. Currently, the market is at USD 23.93 Bn in 2025 and is expected to be around USD 102.58 Bn by 2032. Patients and healthcare providers are increasingly driving medicinal cannabis market growth as awareness rises and more regions legalize its use. Physicians are showing greater acceptance of cannabis-based treatments for chronic conditions like pain, epilepsy, and multiple sclerosis.
"The launch of Daily Special in Germany is a clear demonstration of Aurora's long-term investment and leadership in one of the world's most important medical cannabis markets and key region for the company," said, Andreas Dotterweich, Senior Vice President, Aurora Europe. "As a global leader, we are uniquely positioned to introduce a new brand that we believe will resonate with patients and support the development of Germany's medical cannabis sector as it enters its next phase of growth."
Source:
News Room: Aurora Cannabis Inc.
Company: Aurora Cannabis Inc.
